Psychopharmacology Maastricht
The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.
Learn More
Maastricht Psychedelic Symposium
On May 24, the Maastricht Psychedelic Research Team organized a mini-symposium on psychedelics. We welcomed two international speakers: Prof. dos Santos and Prof. Bouso from Brazil and Spain to discuss their ayahuasca and ibogaine research. We also had several internal speakers: presenting on mystical vs. autobiographical psychedelic experiences (Dr Kangaslampi), microdosing (Ms. Haijen), and 5-MeO-DMT (Mr. Reckweg).
Click below to watch the entire symposium
Read about our new paper on the neurological origins of a visual psychedelic hallucination
Congratulations to Zeus Tipado on his newly published paper that introduces a new theory as to why a person experiences a visual trip on psychedelics.
Read The PaperParticipate in our studies!
We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.
View All Studies
Our Scientists
Prof. Jan Ramaekers
I work as a professor in psychopharmacology at Maastricht University in the Netherlands. My research combines methods from psychopharmacology, forensic toxicology and cognitive neuroscience to determine drug induced changes in human performance.
Eline Haijen, MSc
ADHD, Microdosing, Psychedelics
I am a PhD candidate in the Psychopharmacology in Maastricht research group at the Department of Neuropsychology and Psychopharmacology at Maastricht University. I am from a little village close to Maastricht.
Zeus Tipado, MSc
My neuroscience research is focused on perceptual experiences of psychedelics, specifically visual experiences while under DMT.
Dr. Malin Vedøy Uthaug
Ayahuasca, 5-MeO-DMT, Consciousness
I am an altered states of consciousness researcher from Norway and one of the world leading experts on 5-MeO-DMT.
Iva Totomanova, MSc
My primary research interest lies in exploring the potential of psychedelics to be used as novel treatment options for a range of psychiatric disorders.
Aedan O’Shea, MSc
I have a long standing interest in unravelling the therapeutic mechanisms of Psychedelics, and in this project I will investigate the effect of Psychedelic drug exposure in humans on miRNA’s transported in neuron-derived Extracellular Vesicles...
Sarah Roche, MSc
Psilocybin, Sustainability, Environment
My PhD research focuses on psychedelic drugs as a tool to investigate the cognitive mechanisms underlying changes in sustainable behavior.
Pablo Mallaroni, MSc
Psychedelics, fMRI/MRS, Idiosyncracy
I am PhD candidate with the Psychopharmacology Unit of Maastricht University with a background in translational neuroscience.
Katharina Lege, MSc
Cannabinoids, Neuroimaging, Consciousness
Coming from a background of psychology and clinical neuroscience, I developed a strong interest in altered states of the mind as in mediation or yoga practices.
Psychedelic Research
Visual hallucinations originating in the retinofugal pathway under clinical and psychedelic conditions
retinofugal, tripping, hallucinations, visual, Psychedelics, vision
→
Microdosing psychedelics: More questions than answers? An overview and suggestions for future research
→
Ayahuasca enhances creative divergent thinking while decreasing conventional convergent thinking
convergent thinking, Ayahuasca, creativity, divergent thinking
→
A single inhalation of vapor from dried toad secretion containing 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in a naturalistic setting is related to sustained enhancement of satisfaction with life
5-MeO-DMT, naturalistic, psychopathological
→
Me, myself, bye: regional alterations in glutamate and the experience of ego dissolution with psilocybin
→
Microdosing with psychedelics to self-medicate for ADHD symptoms in adults: A prospective naturalistic study
→
Cannabis Research
Cannabis induced increase in striatal glutamate associated with loss of functional corticostriatal connectivity
Cannabis, Glutamate, Functional Connectivity
→
Intoxication by a synthetic cannabinoid (JWH-018) causes cognitive and psychomotor impairment in recreational cannabis users
Cannabis, Cognition, Psychomotor
→
Get in Touch
We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.